Yanjun Liu Selected Research

phosphatidylglucose

1/2021

Exogenous phosphatidylglucoside alleviates cognitive impairment by improvement of neuroinflammation, and neurotrophin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanjun Liu Research Topics

Disease

45	Neoplasms (Cancer) 10/2022 - 09/2007
24	Type 2 Diabetes Mellitus (MODY) 05/2022 - 01/2005
18	Insulin Resistance 11/2021 - 06/2003
13	Obesity 01/2022 - 06/2003
12	Body Weight (Weight, Body) 01/2022 - 06/2003
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2022 - 04/2012
10	Inflammation (Inflammations) 01/2021 - 01/2010
8	Weight Loss (Weight Reduction) 01/2022 - 06/2003
8	Hyperglycemia 07/2020 - 06/2003
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
6	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2017
6	Neoplasm Metastasis (Metastasis) 08/2020 - 09/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 05/2020
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2013
4	Atherosclerosis 04/2022 - 08/2016
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 06/2015
4	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2008
4	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2017
3	Multiple Myeloma 10/2022 - 06/2018
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2021
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 01/2020
3	Carcinogenesis 07/2021 - 02/2016
3	Abdominal Obesity 11/2019 - 03/2014
3	Hyperlipidemias (Hyperlipidemia) 10/2019 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 04/2012
3	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2017
3	Weight Gain 03/2014 - 08/2008
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2022 - 01/2022
2	Hypoglycemia (Reactive Hypoglycemia) 05/2022 - 08/2020
2	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2022 - 01/2015
2	Hypoxia (Hypoxemia) 05/2022 - 03/2022
2	Fatty Liver 03/2022 - 01/2017
2	Gout 01/2022 - 10/2021
2	Adenocarcinoma 11/2021 - 11/2020
2	Hyperuricemia 10/2021 - 01/2021
2	Unconsciousness (Loss of Consciousness) 07/2021 - 07/2021
2	Stomach Neoplasms (Stomach Cancer) 07/2021 - 03/2015
2	Morbid Obesity 02/2021 - 01/2021
2	Liver Diseases (Liver Disease) 01/2021 - 07/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
14	Insulin (Novolin)FDA Link 05/2022 - 08/2008
10	GlucocorticoidsIBA 11/2019 - 06/2003
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
8	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 02/2011
6	Biological ProductsIBA 04/2022 - 01/2016
6	LipidsIBA 09/2020 - 04/2012
6	EnzymesIBA 06/2017 - 06/2009
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2005
5	Sucrose (Saccharose)IBA 09/2020 - 10/2015
5	Pharmaceutical PreparationsIBA 03/2020 - 06/2009
5	Blood Glucose (Blood Sugar)IBA 11/2019 - 10/2009
5	Nicotine FDA Link 01/2019 - 03/2012
4	BerberineIBA 10/2022 - 10/2009
4	Eicosapentaenoic AcidIBA 04/2022 - 01/2017
4	Therapeutic UsesIBA 01/2022 - 03/2020
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
4	Long Noncoding RNAIBA 01/2021 - 01/2020
4	CytokinesIBA 01/2021 - 01/2010
4	Phosphatidylcholines (Phosphatidylcholine)IBA 09/2020 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 08/2018 - 09/2007
4	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 04/2013
3	RNA (Ribonucleic Acid)IBA 12/2021 - 09/2008
3	Uric Acid (Urate)IBA 10/2021 - 01/2021
3	ChitosanIBA 01/2021 - 02/2016
3	AntioxidantsIBA 01/2021 - 10/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2009
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 07/2011
3	phosphatidylethanolamineIBA 09/2020 - 02/2020
3	UbiquitinIBA 05/2020 - 12/2015
3	Antineoplastic Agents (Antineoplastics)IBA 08/2019 - 01/2018
3	Hormones (Hormone)IBA 01/2019 - 01/2005
3	Peptides (Polypeptides)IBA 01/2018 - 12/2015
3	CorticosteroneIBA 01/2017 - 06/2003
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2008 - 01/2005
3	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 08/2008 - 06/2003
2	Starch (Cornstarch)IBA 12/2022 - 01/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2022 - 04/2022
2	GoldIBA 05/2022 - 01/2021
2	Docosahexaenoic AcidsIBA 04/2022 - 02/2020
2	C-Reactive ProteinIBA 01/2022 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2019
2	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 01/2020
2	Propofol (Diprivan)FDA LinkGeneric 07/2021 - 07/2021
2	MetalsIBA 01/2021 - 06/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2021
2	PolymersIBA 01/2021 - 03/2020
2	InterferonsIBA 01/2021 - 01/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2020 - 02/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2015
2	Immunoconjugates (Immunoconjugate)IBA 10/2019 - 08/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2019 - 01/2016
2	Anthocyanins (Anthocyanin)IBA 04/2019 - 01/2017

Therapy/Procedure

28	Therapeutics 12/2022 - 05/2014
7	Drug Therapy (Chemotherapy) 01/2022 - 09/2013
7	Bariatric Surgery 10/2021 - 01/2019
6	Immunotherapy 01/2022 - 05/2009
2	Photothermal Therapy 05/2022 - 01/2021
2	Gastrectomy 01/2020 - 01/2019
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020 - 01/2019
2	Injections 10/2019 - 12/2012